Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD
Trial ID or NCT#
Status
Purpose
The study hypothesis is that dextro-amphetamine (d-amphetamine) will be safe and effective when used to augment treatment for Obsessive-Compulsive Disorder (OCD), and that tolerance (loss of therapeutic effect) to the medication will not develop over a period of several weeks.
Official Title
Double-blind Trial of Acute and Intermediate-term Dextro-amphetamine Versus Caffeine Augmentation in Treatment Resistant Obsessive Compulsive Disorder (OCD)
Eligibility Criteria
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Lorrin Koran
6507235154
View on ClinicalTrials.gov